Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katherine E, Fisher"'
Publikováno v:
Microorganisms, Vol 11, Iss 1, p 94 (2022)
Current environmental diagnostics for the detection of Legionella fail to detect viable but non-culturable Legionella, have sensitivity limitations and are time-consuming (10–14 days to results). The objective of this study was to compare Legionell
Externí odkaz:
https://doaj.org/article/0f2e50d7cfda44c78cf9cf77852545b8
Publikováno v:
Applied Microbiology; Volume 2; Issue 2; Pages: 347-356
Nontuberculous mycobacteria (NTM) are common in the environment and certain species can cause serious infections. Improved environmental surveillance methods are needed to combat the increased incidence of NTM disease. Recently, two methods were deve
Publikováno v:
Journal of AOAC International. 105(2)
Background The MYChrOme™ Culture Plate is a chromogenic media for the detection and differentiation of rapid-growing nontuberculous mycobacteria (NTM) in water, aided by MYCOn™ decontamination to reduce background microbiota. Objective Evaluate t
Autor:
Michelle A Habib, Rafael M Buford, Katherine E Fisher, William F. McCoy, Anna A Ranz, Leah P Wickenberg, Lesley F. Leonidas
Publikováno v:
Journal of water and health. 18(3)
The opportunistic, waterborne pathogen Legionella caused 9,933 cases of Legionnaires' disease in 2018 in the United States (CDC.gov). The incidence of Legionnaires' disease can be reduced by maintaining clean building water systems through water mana
Autor:
Michael A, Brodney, David E, Johnson, Aarti, Sawant-Basak, Karen J, Coffman, Elena M, Drummond, Emily L, Hudson, Katherine E, Fisher, Hirohide, Noguchi, Nobuaki, Waizumi, Laura L, McDowell, Alexandros, Papanikolaou, Betty A, Pettersen, Anne W, Schmidt, Elaine, Tseng, Kim, Stutzman-Engwall, David M, Rubitski, Michelle A, Vanase-Frawley, Sarah, Grimwood
Publikováno v:
Journal of medicinal chemistry. 55(21)
The cognitive impairments observed in Alzheimer's disease (AD) are in part a consequence of reduced acetylcholine (ACh) levels resulting from a loss of cholinergic neurons. Preclinically, serotonin 4 receptor (5-HT(4)) agonists are reported to modula